Development and Validation of a Brief Version of the Difficulties in Emotion Regulation Scale: The DERS-16.
Johan Bjureberg, Brjánn Ljótsson, Matthew T Tull...
https://pubmed.ncbi.nlm.nih.gov/27239096Actively Recruiting
Led by Yale University · Updated on 2025-07-28
450
Participants Needed
1
Research Sites
25 weeks
Total Duration
Y
Yale University
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
Researchers are evaluating the effectiveness of a 10-session LGBTQ-affirmative cognitive behavioral psychotherapy (CBT) delivered via telehealth for sexual minority women experiencing heavy drinking and mental health issues such as depression and anxiety. This randomized controlled trial compares the EQuIP treatment, which targets minority stress responses contributing to these health disparities, to LGBTQ-affirmative treatment-as-usual. The study aims to identify whether EQuIP reduces heavy drinking and mental health symptoms more effectively and examines psychosocial factors that may influence outcomes across different demographic groups. Participants are randomly assigned to one of two groups: the experimental group receives 10 weekly individual CBT sessions focused on minority stress mechanisms related to depression, anxiety, and alcohol abuse, delivered remotely. The comparator group receives 10 weekly LGBTQ-affirmative therapy sessions via telehealth from therapists at the Institute for Human Identity. Both groups complete sessions over a similar time frame following an initial baseline assessment. During the study, participants undergo assessments at baseline and at 4, 8, and 12 months afterward. These evaluations include measures of heavy drinking, depression and anxiety symptom severity, PTSD symptoms, suicidal ideation, alcohol and drug use, and related problems. Researchers also monitor mental health symptom presence and impairment. The total participation includes these follow-up periods to track changes over time and assess the sustained impact of the treatments.
CONDITIONS
Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 10 weeks
Participants receive 10 weekly sessions of LGBTQ-affirmative psychotherapy delivered via telehealth, either using cognitive behavioral therapy techniques or treatment-as-usual.
Weekly sessions delivered remotely via telehealth
Duration - Up to 8 months after treatment
Participants are monitored for mental health and drinking outcomes after completion of therapy.
3 follow-up visits at 4, 8, and 12 months after baseline assessment
Total: 1 location
1
Yale LGBTQ Mental Health Initiative with the Yale School of Public Office
New York, New York, United States, 10001
Actively Recruiting
J
John E Pachankis, PhD
D
Danielle M Chiaramonte, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Johan Bjureberg, Brjánn Ljótsson, Matthew T Tull...
https://pubmed.ncbi.nlm.nih.gov/27239096L C Sobell, J Brown, G I Leo...
https://pubmed.ncbi.nlm.nih.gov/8889403Tamara G Fong, Sharon K Inouye
https://pubmed.ncbi.nlm.nih.gov/30239466Ariel J Lang, Sonya B Norman, Adrienne Means-Christensen...
https://pubmed.ncbi.nlm.nih.gov/19016462D V Sheehan, Y Lecrubier, K H Sheehan...
https://pubmed.ncbi.nlm.nih.gov/9881538Stewart A Shankman, Carter J Funkhouser, Daniel N Klein...
https://pubmed.ncbi.nlm.nih.gov/29034525J T Sullivan, K Sykora, J Schneiderman...
https://pubmed.ncbi.nlm.nih.gov/2597811Stephen A Maisto, Marketa Krenek, Tammy Chung...
https://pubmed.ncbi.nlm.nih.gov/21767028Katie Witkiewitz, Kevin A Hallgren, Henry R Kranzler...
https://pubmed.ncbi.nlm.nih.gov/28019652John Pachankis, Danielle Chiaramonte, Jillian R Scheer...
https://pubmed.ncbi.nlm.nih.gov/40032395